NCT07116564

Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries

Impact of Multimodal Analgesia and ERAS Protocol on Length of Hospital Stay After Laparoscopic Gynecological Surgeries: A Randomized Control Trial

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 98 (estimated)
• Sponsor: Aga Khan University · Academic / Other
• Sex: Female
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to determine the length of hospital stay in patients using multimodal analgesia with or without ERAS protocol scheduled for elective laparoscopic gynecological surgeries

Conditions

• ERAS

Interventions

Type	Name	Description
DRUG	Enhanced Recovery After Surgery	Preoperatively ERAS protocol includes, No solid food for 6 hours before procedure; 800 ml (fantomalt powder) Carbohydrate drink 8 hours before surgery; 400 ml (fantomalt powder) 2 hours before surgery; Celecoxib 200g 1 hour before surgery . Intraoperatively, on induction lidocaine 1.5 mg/kg and Fentanyl 1 to 2 mcg/kg followed by IV lidocaine infusion at 1.5 mg/kg/h.
DRUG	Control	Preoperatively, NPO 6 hours before the procedure Intraoperatively, on induction Nabuphine 0.1mg/kg

Timeline

• Start date: 2025-08-20
• Primary completion: 2026-08-01
• Completion: 2026-11-01
• First posted: 2025-08-11
• Last updated: 2026-02-17

Locations

1 site across 1 country: Pakistan